Clinical Decision Support System for Remote Monitoring of Cardiovascular Disease Patients: Promoting Self-Management and Adherence to Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Decision Support Systems, Clinical
- Sponsor
- Escola Superior de Enfermagem de Coimbra
- Enrollment
- 212
- Primary Endpoint
- Recurrent cardiovascular event rates
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
Cardiovascular diseases (CVD) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year. The reduction of CVD-related mortality and morbidity is a key global health priority. Cardiac rehabilitation (CR) is a multi-factorial and comprehensive intervention in secondary prevention, being recommended in international guidelines. Core components in CR include patient assessment, physical activity counseling, nutritional counseling, risk factor control, patient education, and psychosocial management. CR has been shown to reduce mortality, hospital readmissions, costs, as well as to improve physical fitness, quality of life, and psychological well-being. However, despite the recommendations and proven benefits, acceptance and adherence remain low. Access to health technologies in all primary and secondary healthcare facilities can be essential to ensure that those in need receive treatment and counseling.
Using mobile health (mHealth) solutions may contribute to more personalized and tailored patient recommendations according to their specific needs. Also, these technologies contribute to increasing the flexibility, quality, and efficiency of the services provided by health institutions.
Time constraints, patient overpopulation, and complex guidelines require alternative solutions for real-time patient monitoring. Rapidly evolving e-health technology combined with clinical decision support systems (CDSS) provides an effective solution to these problems. There are several computerized CDSS for managing chronic diseases; however, to the best of our knowledge, there are none for the e-management of patients with CVD.
The purpose of this transdisciplinary research project is to develop and evaluate a user-friendly, comprehensive CDSS for remote monitoring of CVD patients. The CDSS will suggest a monitoring plan for the patient, advise the mHealth tools (apps and wearables) adapted to patient needs, and collect data. The primary outcome will be the reduction of recurrent cardiovascular events (a composite of cardiovascular rehospitalization or urgent consultation, unplanned revascularization, cardiovascular mortality, or worsening heart failure).
Investigators
Pedro Miguel Lopes de Sousa
Adjunct Professor
Escola Superior de Enfermagem de Coimbra
Eligibility Criteria
Inclusion Criteria
- •Patients attending the cardiology outpatient clinics after the onset of acute cardiac event OR
- •Patients attending the cardiology outpatient clinics who are engaged in a structured Cardiac Rehabilitation program
- •Be able to communicate with the researcher
Exclusion Criteria
- •Participants will be excluded if they have New York Heart Association class III/IV heart failure, terminal disease, or significant non-cardio vascular disease exercise limitations.
Outcomes
Primary Outcomes
Recurrent cardiovascular event rates
Time Frame: Two measurement timepoints: 3-month (T1) and the 6-month (T2)
This outcome is a composite of cardiovascular rehospitalization or urgent visit, unplanned revascularization, cardiovascular mortality, or worsening heart failure
Secondary Outcomes
- Quality of life score (assessed by the MacNew Heart Disease Health-related Quality of Life questionnaire)(Two measurement timepoints: 3-month (T1) and the 6-month (T2))
- Adherence to treatment score (assessed by the Therapeutic Self-care Scale)(Two measurement timepoints: 3-month (T1) and the 6-month (T2))
- Body Mass Index (in Kg/m^2)(Two measurement timepoints: 3-month (T1) and the 6-month (T2))
- Health-Promoting Lifestyle score (assessed by the Health-Promoting Lifestyle Profile-II)(Two measurement timepoints: 3-month (T1) and the 6-month (T2))